Investor Overview

  • We are a biotechnology company pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic human biology and disease.
  • We are developing in vivo liver tissues to treat a range of rare, life-threatening diseases, for which there are few current treatment options other than organ transplantation.
  • We are harnessing our foundational ability to characterize specialized human cells and to 3D bioprint functional tissues to create novel in vitro toxicology and liver disease modeling platforms.
  • We are striving to change the face of medicine through clinical development of regenerative medicine therapies for treating disease and by enabling translational drug discovery.

2018 Annual ReportInvestor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$1.07
Change (%) + 0.01 (0.00%)
Volume468,899
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.07 with a 52 week high of $2.09 and a 52 week low of $0.90.
Recent Investor News
02/07/19
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results
01/17/19
Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results
Investor Events
There are currently no events scheduled.
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet